Post by Simtra BioPharma Solutions

We marked an exciting milestone today at our manufacturing site in Halle/Westfalen, Germany, as construction continues on Simtra’s new deep freeze storage warehouse. Team members, leaders, and guests came together for a ceremonial handprint moment—literally leaving our mark on a facility that will play a critical role in advancing cold-chain capabilities for temperature-sensitive medicines. This $10.3M investment expands our ability to support complex injectable therapies, with 630 temperature-controlled storage locations and ultra-low ranges down to -40°C. The site will strengthen our quality infrastructure, increase capacity, and better serve the growing demand for biologics and advanced therapies. Why this matters:  As therapies become more complex, reliable cold-chain storage is essential to ensuring product integrity and patient safety. This new facility positions Simtra to meet that need—today and into the future. #Simtra #CDMO #ColdChain #Manufacturing #Biologics